|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,461,833 |
|
|
Indirect Value
|
$12,984,280,034 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,066,741,867 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 32 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2004-08-02 |
4 |
B |
$5.89 |
$63,106 |
I/I |
10,571 |
10,571 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-15 |
4 |
B |
$5.66 |
$63,392 |
I/I |
11,206 |
137,687 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
N/A |
|
2006-09-08 |
4 |
B |
$14.12 |
$63,496 |
I/I |
4,481 |
5,318 |
0.01 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-07 |
4 |
B |
$9.48 |
$63,941 |
I/I |
6,744 |
111,197 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-11-07 |
4 |
B |
$7.27 |
$64,167 |
I/I |
8,821 |
104,866 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-20 |
4 |
B |
$3.99 |
$64,366 |
I/I |
16,117 |
1,200,321 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-09 |
4 |
B |
$13.19 |
$64,462 |
I/I |
4,862 |
341,214 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-05-25 |
4 |
B |
$11.95 |
$64,722 |
I/I |
5,416 |
11,119,820 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-10 |
4 |
B |
$5.32 |
$65,400 |
I/I |
12,298 |
74,980 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$65,647 |
I/I |
2,162 |
1,484,977 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$65,937 |
I/I |
(5,183) |
570,585 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-18 |
4 |
B |
$7.15 |
$66,389 |
I/I |
9,238 |
6,498,682 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2009-05-13 |
4 |
B |
$5.45 |
$67,015 |
I/I |
12,279 |
181,798 |
1.5 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.97 |
$67,614 |
I/I |
13,600 |
263,300 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-14 |
4 |
S |
$12.05 |
$68,148 |
I/I |
(5,655) |
1,127,007 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-03 |
4 |
S |
$13.29 |
$68,668 |
I/I |
(5,166) |
473,530 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$70,097 |
I/I |
2,346 |
1,482,815 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-25 |
4 |
B |
$6.00 |
$70,380 |
I/I |
11,730 |
2,487,138 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-04 |
4 |
S |
$13.14 |
$70,709 |
I/I |
(5,380) |
468,150 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-24 |
4 |
B |
$5.98 |
$70,897 |
I/I |
11,847 |
965,513 |
1.5 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$71,043 |
I/I |
(4,829) |
163,559 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-04-29 |
4 |
B |
$3.99 |
$71,061 |
I/I |
17,766 |
75,439 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-01 |
4 |
S |
$14.51 |
$71,406 |
I/I |
(4,920) |
283,366 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-02 |
4 |
B |
$29.52 |
$71,410 |
I/I |
2,419 |
222,642 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-06 |
4 |
S |
$12.14 |
$71,529 |
I/I |
(5,892) |
115,021 |
0 |
- |
|
1397 Records found
|
|
Page 32 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|